Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000185711 | SCV000238633 | likely pathogenic | not provided | 2014-07-03 | criteria provided, single submitter | clinical testing | p.Ala161Val (GCC>GTC): c.482 C>T in exon 7 of the ACADVL gene (NM_000018.2). A161V variant that is likely pathogenic was identified in the ACADVL gene. It has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. The A161V variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. However, this substitution occurs at a position that is highly conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Furthermore, a missense mutation at the same residue (A161T) and in nearby residues (G152D, T158N, Q159R, R162H, V164G) have been reported in association with VLCAD deficiency, supporting the functional importance of this region of the protein. Therefore, this variant is a strong candidate for a pathogenic mutation, however the possibility that it is a benign variant cannot be excluded. The variant is found in FAO-MET panel(s). |
Counsyl | RCV000675132 | SCV000800708 | uncertain significance | Very long chain acyl-CoA dehydrogenase deficiency | 2018-05-16 | criteria provided, single submitter | clinical testing |